Business
Market for Registrant's Common Equity, Related Stockholder Matters, and Issuer Purchases of Equity Securities 74 ITEM 6.
Silence Therapeutics plc: Revenue declined 98.7% to $559K from $43.26M. Net loss widened to $88.61M from $45.31M. Free cash flow outflow narrowed to $62.33M from $67.85M. Operating margin contracted 1614646 bps to -16292.84%. Silence Therapeutics plc's annual comparison also shows the balance-sheet screen falls in the distress range and requires business-model context; the earnings-quality screen is grey.
The read at a glance✓ Audited against SEC data
- Growth — Revenue declined 98.7% to $559K from $43.26MWatch
- Profitability — Net loss widened to $88.61M from $45.31MWatch
- Cash flow — Free cash flow outflow narrowed to $62.33M from $67.85MOK
- Margins — Operating margin contracted 1614646 bps to -16292.84%Watch
- Accounting — Distress-range screen needs contextWatch
- Insiders — 0 purchases and 0 salesNote
Where the revenue comes from
Fiscal 2025, as Silence Therapeutics plc reports it. History and quarterly detail are in the app.
- Research Collaboration Income$559K
Leadership changes
From Silence Therapeutics plc's own filings, the day they're filed.
- Rhonda Hellums · Chief Financial Officer · appointmenteff. 2025-12-18
- Craig Tooman · Chief Executive Officer · departureeff. 2025-12-14
- Michael Davidson · directors · departureeff. 2025-08-11
Latest filings
- 8-K · Company announcement2026-08-12
- 8-K · Company announcement2026-08-10
- 10-Q · Quarterly report2026-08-10
- 8-K · Company announcement2026-08-10
- 8-K · Company announcement2026-06-23
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Silence Therapeutics plc, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.